Literature DB >> 9405412

Depression of T-cell epitope generation by stabilizing hen lysozyme.

T So1, H O Ito, T Koga, S Watanabe, T Ueda, T Imoto.   

Abstract

Conformational stability of proteins is an important factor that determines their resistance/susceptibility to proteolytic digestion. Intracellular proteolysis is the key step in antigen presentation events for protein antigens; hence, it is likely that increasing protein stability reduces the antigenicity of proteins. We prepared three hen egg white lysozyme derivatives possessing different stabilities by chemical modification to clarify the relationship between conformational stability and the antigenicity of the protein. One of the derivatives was conformationally unstabilized by removing one intramolecular disulfide bond, whereas the two others were stabilized by the addition of an intramolecular cross-link. The antigenicity of these derivatives was evaluated using hen egg white lysozyme-specific T-cell hybridoma cells and a B-lymphoma cell line, A20, as antigen-presenting cells. With an increase in conformational stability, the T-cell response decreased. However, the reduction was not derived from the inefficiency of internalization to A20 cells nor the alteration of antigenicity by chemical modifications. Moreover, from analyses of their susceptibility to proteolysis and the kinetics of presentation of the T-cell epitope, it was confirmed that increasing protein stability led to the depression of T-cell epitope generation by increasing resistance to proteolysis. These results have an important implication in devising a new strategy for manipulating T-cell response by the stability of protein antigen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405412     DOI: 10.1074/jbc.272.51.32136

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.

Authors:  John T Bates; Aaron H Graff; James P Phipps; Jason M Grayson; Steven B Mizel
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 2.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  Three-dimensional structure determines the pattern of CD4+ T-cell epitope dominance in influenza virus hemagglutinin.

Authors:  Samuel J Landry
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

4.  T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions.

Authors:  Taylor R Dagenais; Karen P Demick; James D Bangs; Katrina T Forest; Donna M Paulnock; John M Mansfield
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

5.  Contribution of conformational stability of hen lysozyme to induction of type 2 T-helper immune responses.

Authors:  T So; H Ito; M Hirata; T Ueda; T Imoto
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

6.  Redirecting the humoral immune response against Streptococcus mutans antigen P1 with monoclonal antibodies.

Authors:  Monika W Oli; Nikki Rhodin; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.

Authors:  Nikki R Rhodin; Marloes L J A Van Tilburg; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Deimmunizing substitutions in Pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes.

Authors:  Daniel L Moss; Hee-Won Park; Ramgopal R Mettu; Samuel J Landry
Journal:  J Biol Chem       Date:  2019-01-25       Impact factor: 5.157

9.  Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

Authors:  Lélia Delamarre; Rachael Couture; Ira Mellman; E Sergio Trombetta
Journal:  J Exp Med       Date:  2006-08-14       Impact factor: 14.307

10.  Improved drug-like properties of therapeutic proteins by directed evolution.

Authors:  Andrew Buchanan; Franco Ferraro; Steven Rust; Sudharsan Sridharan; Ruth Franks; Greg Dean; Matthew McCourt; Lutz Jermutus; Ralph Minter
Journal:  Protein Eng Des Sel       Date:  2012-08-31       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.